Lin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lin Liu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Liu Liu
Department of general surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
2 shared publicationsHaiyan Wang
Department of General Surgery, Anhui Provincial Hospital, Bengbu Medical University, China
1 shared publicationShengyuan Miao
Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University, Hefei, China
1 shared publicationShijie Feng
Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, China
1 shared publication- Shoudong Ye
Center for Stem Cell and Translational Medicine School of Life Sciences and Medical Engineering Anhui University Hefei China
1 shared publication Wei Lu
Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University, Hefei, China
1 shared publication
Latest Publications
- Open Access
- 24 March 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
NCBP2 drives colorectal cancer growth and metastasis through LIPG-mediated lipid droplet accumulation
RNA-binding proteins play critical roles in RNA processing and are aberrantly expressed in colorectal cancer (CRC). Through comprehensive analysis of multiple gene expression datasets (GSE20916, GSE18105, GSE21510, TCGA-COAD and TCGA-READ), NCBP2 was identified as a potential tumorigenic gene in CRC. NCBP2 expression was significantly elevated in CRC tissues, correlated with tumour invasion and metastasis, and associated with poor patient survival outcomes. Furthermore, overexpression of NCBP2 in CRC cells was shown to increase cell proliferation, migration, and tumour invasion in both in vitro and in vivo models. Mechanistically, the NCBP2 protein stabilised LIPG mRNA via direct binding to the m7G motif in the 5’-cap structure of LIPG mRNA, thereby increasing LIPG expression. Additionally, NCBP2 promoted lipid droplet accumulation in CRC cells in a LIPG-dependent manner. These findings collectively suggest that the NCBP2-LIPG-lipid droplet axis represents a novel mechanism underlying CRC progression and metastasis, providing a promising therapeutic target for CRC treatment.
- 24 March 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessNCBP2 drives colorectal cancer growth and metastasis through LIPG-mediated lipid droplet accumulation
RNA-binding proteins play critical roles in RNA processing and are aberrantly expressed in colorectal cancer (CRC). Through comprehensive analysis of multiple gene expression datasets (GSE20916, GSE18105, GSE21510, TCGA-COAD and TCGA-READ), NCBP2 was identified as a potential tumorigenic gene in CRC. NCBP2 expression was significantly elevated in CRC tissues, correlated with tumour invasion and metastasis, and associated with poor patient survival outcomes. Furthermore, overexpression of NCBP2 in CRC cells was shown to increase cell proliferation, migration, and tumour invasion in both in vitro and in vivo models. Mechanistically, the NCBP2 protein stabilised LIPG mRNA via direct binding to the m7G motif in the 5’-cap structure of LIPG mRNA, thereby increasing LIPG expression. Additionally, NCBP2 promoted lipid droplet accumulation in CRC cells in a LIPG-dependent manner. These findings collectively suggest that the NCBP2-LIPG-lipid droplet axis represents a novel mechanism underlying CRC progression and metastasis, providing a promising therapeutic target for CRC treatment.
- Open Access
Short-term outcome of totally laparoscopic gastrectomy for gastric cancer: a comparative study